The aging population of the United States creates pharmaceutical challenges for the practicing emergency physician. Polypharmacy, drug-drug and drug-disease interactions, and other pharmaceutical complications from the pathophysiologic changes associated with aging need to be recognized in order to optimize outcomes in the elderly. Effective strategies that improve patients outcomes include a better understanding of the physiologic and pharmacologic changes that occur with aging, integrated use of clinical emergency department pharmacists, and choosing nonpharmacologic treatment options when possible.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2afml5Q
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Prolonged QT interval (long QTc) predisposes to torsades de pointes, which can present with seizures, syncope, and sudden death. (...
-
Researchers found that cardiac arrest survival rates remain low in the U.K. due to the lack of knowledge and skills to perform CPR from EM...
-
Abstract Introduction Population-based knowledge on the occurrence of specific injuries is essential for the allocation of health care s...
-
No abstract available from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2SVDgBd
-
AbstractIntroductionThreatened, perforated, and infarcted bowel is managed with conventional resection and anastomosis (hand sewn (HS) or st...
-
Objectives Self-rated health (SRH) is an important patient-reported outcome, but little is known about SRH after a visit to the emergency de...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου